Precise detection of sperm DNA breaks and AP sites based on TDT and strand displacement probes

Bei Yan1, Ziyang Liu2, Heng Fan3

  • 1Human sperm bank, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, 750004, China; Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China; Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, 410007, China.

Analytica Chimica Acta
|September 22, 2025
PubMed
Abstract

Insights

A new biosensor accurately detects sperm DNA damage, including DNA breakpoints and AP sites. This method improves diagnosis for male infertility and recurrent pregnancy loss, outperforming older techniques.

Area of Science:

  • Reproductive biology and genetics
  • Biomedical engineering
  • Clinical diagnostics

Background:

  • Sperm DNA damage is linked to male infertility, miscarriage, and offspring health issues.
  • Existing detection methods lack accuracy, comprehensive indicators, and reproducibility.
  • There's a critical need for advanced detection technologies and precise evaluation standards.

Purpose of the Study:

  • To develop an innovative biosensor for simultaneous detection of sperm DNA damage biomarkers.
  • To improve the accuracy and reproducibility of sperm DNA damage assessment.
  • To enhance clinical efficacy in diagnosing male reproductive health issues.

Main Methods:

  • Developed a biosensor utilizing terminal deoxynucleotidyl transferase (TdT) and strand displacement (SD) probes.
  • Enabled simultaneous detection of DNA breakpoints and apurinic/apyrimidinic (AP) sites.
  • Incorporated standardized reference controls to enhance assay accuracy and reproducibility.

Main Results:

  • The novel assay accurately quantified sperm DNA breakpoints and AP sites simultaneously.
  • Applied to analyze sperm samples from diverse patient groups, including asthenozoospermia and recurrent pregnancy loss (RPL).
  • Combined detection of DNA breakpoints and AP sites showed superior sensitivity and specificity in predicting RPL compared to individual markers.

Conclusions:

  • The advanced technology provides comprehensive and precise quantification of sperm DNA damage.
  • Demonstrated superior clinical relevance for diagnosing RPL and asthenozoospermia.
  • Offers a powerful tool for male infertility research and holds significant clinical application promise.